Recon: Pfizer seeks FDA authorization for second COVID-19 booster shot for people 65 and older; Growing list of drugmakers cutting Russia investments
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy